Related Experiment Videos
Cortical blindness due to cyclosporin
M L Van Leeuwen1, T Van Gelder, H M Van Gemert
1Department of Internal Medicine, University Hospital, Rotterdam, Netherlands.
The Netherlands Journal of Medicine
|August 1, 1993
Summary
Cyclosporin, an immunosuppressant, can cause temporary cortical blindness in kidney transplant patients. Reducing the cyclosporin dose can resolve this vision problem.
Area of Science:
- Nephrology
- Ophthalmology
- Pharmacology
Background:
- Kidney transplantation is a life-saving procedure for end-stage renal disease.
- Cyclosporin is a commonly used immunosuppressant to prevent organ rejection post-transplant.
Observation:
- A kidney transplant recipient developed sudden onset cortical blindness.
- The patient was undergoing treatment with cyclosporin for immunosuppression.
Findings:
- The cortical blindness was directly attributed to cyclosporin toxicity.
- Vision impairment resolved spontaneously upon reduction of the cyclosporin dosage.
Implications:
- Highlights the potential neurotoxic side effects of cyclosporin, specifically visual disturbances.
- Emphasizes the importance of monitoring for and managing cyclosporin-induced toxicity in transplant recipients.
- Suggests that careful dose adjustment can mitigate adverse visual events, preserving patient quality of life.